Jason P Burke

USPTO Granted Patents = 19 (Patent Applications = 6)

CIPO Patents = 3

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 6.4

ph-index = 6

Forward Citations = 103(Granted Patents)

Company Filing History:

12 out of 5,444

University of Texas System

patents

3 out of 1,153

Vanderbilt University

Conocophillips Company

patents

Years Active: 2017-2025

Loading Chart...

19 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12264557 - Reverse circulator and method (2025-04-01),

2. 12252480 - Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide (2025-03-18),

3. 12055447 - Systems and methods of pressure testing coiled tubing (2024-08-06),

4. 11958849 - GLS1 inhibitors for treating disease (2024-04-16),

5. 11932643 - Substituted heterocyclic inhibitors of PTPN11 (2024-03-19),

6. 11713313 - GLS1 inhibitors for treating disease (2023-08-01),

7. 11603365 - Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide (2023-03-14),

8. 11370786 - GLS1 inhibitors for treating disease (2022-06-28),

9. 10954243 - Substituted heterocyclic inhibitors of PTPN11 (2021-03-23),

10. 10954193 - Substituted indole Mcl-1 inhibitors (2021-03-23),

11. 10899740 - Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide (2021-01-26),

12. 10766892 - GLS1 inhibitors for treating disease (2020-09-08),

13. 10738043 - GLS1 inhibitors for treating disease (2020-08-11),

14. 10344025 - GLS1 inhibitors for treating disease (2019-07-09),

15. 10150753 - Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide (2018-12-11),

Title: The Innovative Journey of Inventor Jason P Burke from Houston, TX

Introduction:

Jason P Burke, a brilliant inventor hailing from Houston, TX, has made significant strides in the field of medicine with his groundbreaking patents and contributions. With a total of 15 patents to his name, Jason's innovative spirit and dedication to improving healthcare have not gone unnoticed.

Latest Patents:

Among his latest patents is the development of GLS1 inhibitors for treating diseases, particularly cancer. These compounds and compositions, as per Formula I, exhibit promising potential in the treatment of GLS1 mediated diseases. Moreover, Jason's methods for inhibiting GLS1 activity in human or animal subjects showcase his commitment to advancing therapeutic interventions.

Career Highlights:

Jason P Burke has honed his skills and expertise through collaborations with esteemed institutions such as the University of Texas System and Vanderbilt University. His tenure at these renowned establishments has enabled Jason to delve deeper into his research and bring forth innovative solutions to complex medical challenges.

Collaborations:

Throughout his career, Jason has had the privilege of working alongside accomplished professionals like Philip Jones and Michael J Soth. These collaborations have not only enriched his inventions but have also fostered an environment of knowledge sharing and collective growth within the scientific community.

Conclusion:

Inventor Jason P Burke's journey is a testament to the power of innovation and perseverance in the realm of medical discoveries. His relentless pursuit of excellence and passion for transforming healthcare have positioned him as a notable figure in the field of inventions. With a bright future ahead, Jason continues to pave the way for cutting-edge solutions that have the potential to revolutionize the healthcare landscape.

This text is generated by artificial intelligence and may not be accurate.